Intellectual Property

Rochelle Mello is an associate in Arnold & Porter LLP's London office. She is a member of the compliance, anti-bribery/anti-corruption, litigation, and intellectual property practice groups, and has acted for clients in a broad range of sectors, including: Pharmaceuticals, tobacco, cosmetics, media and information technology.

Rochelle has advised multinational companies in connection with investigations before the US Department of Justice (DOJ) and UK Serious Fraud Office (SFO) and has represented clients in the UK’s High Court and Court of Appeal.

Rochelle has recently been on secondment with a global cosmetics company, where she acts as regional compliance counsel helping the company enforce its anti-corruption controls in over 35 diverse markets in Europe, the Middle East, and Africa (EMEA). This has involved day-to-day oversight and implementation of the company’s global anti-corruption policy and procedures, including training managers in local markets. In addition, Rochelle has been part of the Arnold & Porter task force involved in the continuing assessment and development of this client’s anti-corruption program.

Rochelle also has substantial experience in the protection and enforcement of intellectual property rights and has represented numerous companies in connection with patent, trademark, copyright, and other matters. Her work includes representation of several major pharmaceutical companies in matters ranging from enforcement of patents in the UK courts, to advising on Supplementary Protection Certificates (SPCs) and parallel import issues. She has also acted for publishing and media clients in complex and high-profile copyright and passing off disputes.

Rochelle trained at Arnold & Porter (UK) LLP, and also spent time in the firm's Brussels office.

Intellectual Property Representative Matters

• Acting regional compliance counsel for EMEA for a global cosmetics company. Assisting with development, training, implementation, and ongoing assessment of the company’s anti-corruption program. (2011)
• part of a US/European team, advising a multinational company on simultaneous anti-corruption investigations before the US DOJ and the UK SFO. (2010-2011)
• Advising international companies on the implications of the UK Bribery Act, in particular issues regarding scope, jurisdiction, and the new corporate offence. Advising on the overlap between the Bribery Act and FCPA in consultation with US colleagues. (2010-2011)
• Alizyme (in liquidation). Advising post liquidation on intellectual property and commercial issues arising from various patent licences. (2009-2011)
• Special Administrators of the Estate of Michael Jackson. Advising on copyright and trade mark matters. (2009-2011)
• Numatic International Ltd v. Qualtex UK Ltd. Advising Numatic in a passing off action relating to vacuum cleaners. (2008-2010)
• The Wellcome Foundation & Others v. Abbott Laboratories. Advising GlaxoSmithKline plc in patent licence dispute with Abbott. (2007-2009)
• Allergan. Advising Allergan on parallel trade and trade mark infringement matters. (2008)
• Virgin Media Ltd. Advising Virgin Media in a dispute against software developers relating to the release of customer information. Providing general advice on p2p software and the liability of ISPs for IPR infringement. (2008)
• Michael Baigent and Richard Leigh v. The Random House Group Ltd. Assisting on leading copyright infringement case in relation to the best-selling novel The Da Vinci Code. (2006)